Back to results
CompletedPhase 1

Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1

NCT01234012

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Roswell Park Cancer Institute

Buffalo, New York, United States

+1 additional location

View on ClinicalTrials.gov
Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1 — TrialFind